Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry
28 August 2022 (15:15 - 16:00)
Organised by:
Abstract
Slides
About the speaker
Karolinska Institute, Stockholm (Sweden)
6 More presentations in this session
Miss C. Garred (Herlev, DK)
Associate Professor Z. Cox (Nashville, US)
Doctor K. Odegaard (Oslo, NO)
Access the full session
The Event
ESC Congress 2022
28 August 2022
15:15 CET
You may be interested in
Congress Presentation
